Sarepta Therapeutics, Inc. (NASDAQ: SRPT) disclosed that it has awarded equity awards on Feb. 26, 202. These awards were earlier authorized by the Compensation Committee of its Board of Directors under the 2014 Employment Commencement Incentive Plan of Sarepta. The equity awards were accepted in compliance with the Nasdaq Listing Rule 5635(c)(4).
SRPT revealed that its workers will get the total, the choice to buy 1,820 shares of Sarepta's common stock, and in the total 680 restricted stock units (PSUs). The choice has an exertion price of $87.06 per share, which is equivalent to the closure price of the common stock of SRPT on Feb. 26, 2021.
Shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) were moving up 2.12%. It has a closing price of 87.06. SRPT share price went from a low point around $77.01 to briefly above $181.83 in the past 52 weeks. SRPT market cap has stayed high, reaching $7.11 billion at the time of writing. The most recent rating by Citigroup, on Jan 12, 2021, is at Neutral from Buy.
Furthermore, 1/4th of the shares underpinning each staff's choice will be paid out on the first anniversary of the Grant Date. 1/48th of the shares underpinning each worker's choice will be paid out every month, such that the shares underpinning each employee's option will be fully paid out on the fourth anniversary of the Grant Date, in each case, pertaining to each employee's ongoing presence.
Likewise, on each anniversary of the Grant Date, 1/4thof the RSUs shall be granted annually in such a way that the RSUs given to each employee shall be completely granted on the fourth anniversary of the Grant Date, pertaining in each case to the ongoing employment of each such employee with Sarepta on that vesting date.